Gillings, Nicholas M.
Elsinga, Philip H.
Article History
Received: 19 April 2021
Accepted: 21 May 2021
First Online: 28 May 2021
Declarations
:
: The authors declare no competing financial interests. Nic Gillings is first author of the spotlighted article and is member of the EANM Radiopharmacy Committee. Philip Elsinga is co-author of the spotlighted article and Editor-in-Chief of European Journal of Nuclear Medicine and Molecular Imaging Radiopharmacy and Chemistry.
: All authors gave their consent for publication.
Free to read: This content has been made available to all.